Supplementary Figure 2 from The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 86K, Hsp90 stabilizes MET-Y1248H kinase activity and protects mutant MET from crizotnib inhibition in vitro.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362461052